Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05550194
PHASE4

VZV in the Enteric Nervous System: Pathogenesis and Consequences

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

Varicella zoster virus (VZV) is the cause of chickenpox and shingles, but it also infects, becomes latent, and reactivates in nerve cells of the bowel to cause a gastrointestinal disorder ("enteric shingles"). The Investigators recently found that a chronic active VZV infection, a form of enteric shingles, is associated with achalasia, a severe disease in which the passage of food from esophagus to stomach is impaired. We now propose to eradicate VZV to determine whether its association with achalasia is causal, to identify the genetic basis behind VZV reactivation in the esophagus, and the relationship of mast cells to enteric shingles and abdominal pain.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-03-27

Completion Date

2026-08

Last Updated

2025-05-16

Healthy Volunteers

No

Conditions

Interventions

DRUG

ValACYclovir 1000 MG

Valacyclcovir is a targeted anti-viral for varicella zoster virus (VZV).

BIOLOGICAL

Shingrix

Vaccine indicated for prevention of herpes zoster

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States